Fostair Inhaler

Fostair is a combination inhaler containing beclometasone dipropionate (a corticosteroid) and formoterol fumarate dihydrate (a long-acting bronchodilator).

It is used for the regular treatment of asthma in adults whose symptoms are not adequately controlled on a steroid inhaler alone, or who are already stabilised on a steroid and long-acting bronchodilator.

It is also used in adults with severe chronic obstructive pulmonary disease (COPD).

Beclometasone reduces inflammation and swelling in the airways. Formoterol relaxes airway smooth muscle to improve airflow.

Together, they help control ongoing symptoms and reduce the risk of flare-ups when used regularly.

• Adults with asthma not controlled on inhaled corticosteroids alone
• Adults stabilised on steroid and long-acting bronchodilator therapy
• Adults with severe COPD

Not suitable for children and adolescents under 18 years.

Use exactly as prescribed. Your doctor or asthma nurse will confirm whether you are using Fostair:

• As maintenance treatment only (with a separate reliever inhaler), or
• As maintenance and reliever therapy (MART)

Fostair is for inhalation through the mouth only.

Usual Adult Doses – Asthma

1. Maintenance therapy (with a separate reliever inhaler)

• 1–2 inhalations twice daily (morning and evening)
• Maximum: 4 inhalations per day
• You must carry your fast-acting reliever inhaler for sudden symptoms.

2. Maintenance and Reliever Therapy (MART)

• Maintenance: 1 inhalation twice daily
• Reliever: 1 additional inhalation as needed
• If symptoms persist after a few minutes, a second inhalation may be taken
• Maximum: 8 inhalations per day (total)

If you require frequent extra doses, your asthma may not be well controlled and medical review is advised.

Adult Doses – COPD

For severe COPD:

• 2 inhalations twice daily (morning and evening)
• MART is not used in COPD. A separate reliever inhaler may still be required.

Missed Dose

Take the missed dose when remembered, unless it is nearly time for the next one.

Do not double the dose.

The NEXThaler is breath-operated and releases a dose when you inhale strongly.

Steps:

1. Open the cover fully until you hear a click.
2. Breathe out gently, away from the inhaler.
3. Place the mouthpiece between your lips and breathe in quickly and deeply.
4. Hold your breath for 5–10 seconds, then breathe out slowly.
5. Close the cover after use.

The dose counter shows remaining doses.
Rinse your mouth after each dose to reduce the risk of thrush.

How to Use Fostair Pressurised Inhaler (pMDI)

This is a press-and-breathe inhaler.

Before first use or if unused for several days:

Release two test sprays into the air.

To take a dose:

1. Stand or sit upright and remove the cap.
2. Breathe out gently.
3. Place the mouthpiece in your mouth.
4. Start breathing in slowly and press the canister once.
5. Continue to breathe in fully.
6. Hold your breath for 5–10 seconds, then breathe out slowly.

If a second puff is required, wait 30 seconds and repeat.
A spacer may be used if advised.
Rinse your mouth after use.

Active ingredients:

• Beclometasone dipropionate
• Formoterol fumarate dihydrate

Other ingredients (pressurised inhaler):

• Norflurane (HFA propellant)
• Ethanol (anhydrous)

Other ingredients (NEXThaler dry powder):

• Lactose monohydrate (contains small amounts of milk protein)

Refer to the Patient Information Leaflet (PIL) for the full list of ingredients and excipients.

• Not for sudden asthma attacks unless prescribed as part of a MART regimen
• Do not stop using without medical advice
• Inform your prescriber if you have heart conditions, thyroid disorders, diabetes or a history of tuberculosis

Always attend regular asthma or COPD reviews.

• Store below 25°C
• Keep out of sight and reach of children
• Do not use after the expiry date
• Return used or expired inhalers to a pharmacy for safe disposal.